Advanced search
Publication Cover
Expert Review of Ophthalmology Volume 7, 2012 - Issue 5
Submit an article Journal homepage
344
Views
68
CrossRef citations to date
0
Altmetric
Review

Diabetic retinopathy management guidelines

Rahul Chakrabarti Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, Victoria 3002, Australia; Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, Victoria 3002, Australia. [email protected]
,
C Alex Harper Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, Victoria 3002, Australia; Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, Victoria 3002, Australia. [email protected]
&
Jill Elizabeth Keeffe Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, Victoria 3002, Australia; Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, Victoria 3002, Australia. [email protected]
Pages 417-439 | Published online: 09 Jan 2014

References

  • Field M, Lohr K. Clinical Practice Guidelines: Directions for a New Program. National Academy Press, Washington, DC, USA (1992).
  • The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 88(7), 583–600 (1981).
  • Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98(Suppl. 5), 766–785 (1991).
  • Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 298(8), 902–916 (2007).
  • Friedman DS, Ali F, Kourgialis N. Diabetic retinopathy in the developing world: how to approach identifying and treating underserved populations. Am. J. Ophthalmol. 151(2), 192–194.e1 (2011).
  • Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann. Intern. Med. 139(6), 493–498 (2003).
  • AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual. Saf. Health Care, 12(1), 18–23 (2003).
  • WHO. Diabetes fact sheet. WHO, Geneva, Switzerland (2011).
  • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5), 1047–1053 (2004).
  • Ahmed K. Incidence of diabetic retinopathy: a 15 year follow-up in a hospital population (Bangladesh). In: Institute of General practice and Community Medicine. University of Oslo, Oslo, Norway (2009).
  • Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest. Ophthalmol. Vis. Sci. 46(7), 2328–2333 (2005).
  • Ramachandran A, Snehalatha C, Vijay V, King H. Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet. Med. 19(2), 130–135 (2002).
  • Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br. J. Ophthalmol. 83(8), 937–940 (1999).
  • Ruamviboonsuk P, Wongcumchang N, Surawongsin P, Panyawatananukul E, Tiensuwan M. Screening for diabetic retinopathy in rural area using single-field, digital fundus images. J. Med. Assoc. Thai. 88(2), 176–180 (2005).
  • Javadi MA, Katibeh M, Rafati N et al. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol. 9, 12 (2009).
  • Wang FH, Liang YB, Zhang F et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 116(3), 461–467 (2009).
  • Mash B, Powell D, du Plessis F, van Vuuren U, Michalowska M, Levitt N. Screening for diabetic retinopathy in primary care with a mobile fundal camera – evaluation of a South African pilot project. S. Afr. Med. J. 97(12), 1284–1288 (2007).
  • Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res. Clin. Pract. 74(3), 301–308 (2006).
  • Kohner EM, Aldington SJ, Stratton IM et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch. Ophthalmol. 116(3), 297–303 (1998).
  • Klein R, Klein BE, Moss SE. The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes. Metab. Rev. 5(7), 559–570 (1989).
  • Kuper H, Polack S, Limburg H. Rapid assessment of avoidable blindness. Community Eye Health 19(60), 68–69 (2006).
  • Raman R, Rani PK, Reddi Rachepalle S et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 116(2), 311–318 (2009).
  • Namperumalsamy P, Kim R, Vignesh TP et al. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br. J. Ophthalmol. 93(4), 429–434 (2009).
  • King H, Keuky L, Seng S, Khun T, Roglic G, Pinget M. Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet 366(9497), 1633–1639 (2005).
  • International Diabetes Federation. IDF Diabetes Atlas, 5th Edition. International Diabetes Federation, Brussels, Belgium (2011).
  • Diabetes in the UK. Key Statistics on Diabetes. Diabetes UK, London, UK (2010).
  • ADA. Diabetes Statistics. American Diabetes Association, Alexandria, VA, USA (2011).
  • Tapp RJ, Shaw JE, Harper CA et al. AusDiab Study Group. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26(6), 1731–1737 (2003).
  • Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 376(9735), 124–136 (2010).
  • Yau JW, Rogers SL, Kawasaki R et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3), 556–564 (2012).
  • Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102(4), 647–661 (1995).
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood–glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 352(9131), 837–853 (1998).
  • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. BMJ 317(7160), 703–713 (1998).
  • Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive Type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 61(3), 1086–1097 (2002).
  • van Leiden HA, Dekker JM, Moll AC et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care 25(8), 1320–1325 (2002).
  • Chaturvedi N, Sjolie AK, Stephenson JM et al. Effect of lisinopril on progression of retinopathy in normotensive people with Type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351(9095), 28–31 (1998).
  • Klein R, Moss SE, Klein BE. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology 100(8), 1140–1146 (1993).
  • Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 100(6), 862–867 (1993).
  • Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 13(1), 34–40 (1990).
  • Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial Type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24(7), 1275–1279 (2001).
  • Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of Type 1 diabetes mellitus. JAMA 287(19), 2563–2569 (2002).
  • Chew EY, Ambrosius WT, Davis MD et al. ACCORD Study Group; ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in Type 2 diabetes. N. Engl. J. Med. 363(3), 233–244 (2010).
  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 102(4), 520–526 (1984).
  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol. 102(4), 527–532 (1984).
  • Klein BE, Moss SE, Klein R. Is menarche associated with diabetic retinopathy? Diabetes Care 13(10), 1034–1038 (1990).
  • Harvey JN. The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy. Diabetologia 54(8), 1943–1945 (2011).
  • Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care 29(6), 1263–1268 (2006).
  • Danaei G, Finucane MM, Lu Y et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785), 31–40 (2011).
  • Raymond NT, Varadhan L, Reynold DR et al. UK Asian Diabetes Study Retinopathy Study Group. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 32(3), 410–415 (2009).
  • Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15(12), 1875–1891 (1992).
  • Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet. Med. 24(2), 137–144 (2007).
  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 107(2), 237–243 (1989).
  • Raman V, Campbell F, Holland P et al. Retinopathy screening in children and adolescents with diabetes. Ann. N. Y. Acad. Sci. 958, 387–389 (2002).
  • Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with Type 1 diabetes. Ophthalmology 116(3), 497–503 (2009).
  • Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW; DPV-Wiss Study Group. Diabetic retinopathy in Type 1 diabetes – a contemporary analysis of 8,784 patients. Diabetologia 54(8), 1977–1984 (2011).
  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Retinopathy in young-onset diabetic patients. Diabetes Care 8(4), 311–315 (1985).
  • Gallego PH, Wiltshire E, Donaghue KC. Identifying children at particular risk of long-term diabetes complications. Pediatr. Diabetes 8(Suppl. 6), 40–48 (2007).
  • Majaliwa ES, Munubhi E, Ramaiya K et al. Survey on acute and chronic complications in children and adolescents with Type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania. Diabetes Care 30(9), 2187–2192 (2007).
  • Loukovaara S, Immonen IR, Loukovaara MJ, Koistinen R, Kaaja RJ. Glycodelin: a novel serum anti-inflammatory marker in Type 1 diabetic retinopathy during pregnancy. Acta Ophthalmol. Scand. 85(1), 46–49 (2007).
  • Khaldi N, Essid M, Malek I et al. [Proliferative diabetic retinopathy inauguring gestational diabetes]. Ann. Endocrinol. (Paris) 69(5), 449–452 (2008).
  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of Type 2 diabetes: a systematic review. Diabetes Care 25(10), 1862–1868 (2002).
  • The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care, 23(8), 1084–1091 (2000).
  • Rosenn B, Miodovnik M, Kranias G et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am. J. Obstet. Gynecol. 166(4), 1214–1218 (1992).
  • Chew EY, Mills JL, Metzger BE et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 18(5), 631–637 (1995).
  • Rasmussen KL, Laugesen CS, Ringholm L, Vestgaard M, Damm P, Mathiesen ER. Progression of diabetic retinopathy during pregnancy in women with Type 2 diabetes. Diabetologia 53(6), 1076–1083 (2010).
  • Vestgaard M, Ringholm L, Laugesen CS, Rasmussen KL, Damm P, Mathiesen ER. Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes. Diabet. Med. 27(4), 431–435 (2010).
  • Stalnikiewicz L, Floriot M, Guerci B, Angioi K. [Progression of diabetic retinopathy during pregnancy: a retrospective analysis of a series of 77 consecutive patients]. J. Fr. Ophtalmol. 33(7), 481–486 (2010).
  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98(Suppl. 5), 786–806 (1991).
  • Wilkinson CP, Ferris FL 3rd, Klein RE et al. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9), 1677–1682 (2003).
  • Harding S, Greenwood R, Aldington S et al. Diabetic Retinopathy Grading and Disease Management Working Party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet. Med. 20(12), 965–971 (2003).
  • Leese GP, Morris AD, Olson J. A national retinal screening programme for diabetes in Scotland. Diabet. Med. 20(12), 962–964 (2003).
  • RCO. Guidelines for diabetic retinopathy 2005. RCO, London, UK, 2–72 (2005).
  • Goldberg M, Fine S. Symposium on the Treatment of Diabetic Retinopathy, Airlie House. Department of Health, Education and Welfare, Warrenton, VA, USA, 1–913 (1968).
  • Davis MD, Fisher MR, Gangnon RE et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest. Ophthalmol. Vis. Sci. 39(2), 233–252 (1998).
  • Krishnaiah S, Das T, Nirmalan PK et al. Risk factors for diabetic retinopathy: findings from the Andhra Pradesh Eye Disease Study. Clin. Ophthalmol. 1(4), 475–482 (2007).
  • Jaross N, Ryan P, Newland H. Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2. Clin. Experiment. Ophthalmol. 33(1), 26–33 (2005).
  • Xie J, Arnold AL, Keeffe J et al. Prevalence of self-reported diabetes and diabetic retinopathy in indigenous Australians: the National Indigenous Eye Health Survey. Clin. Experiment. Ophthalmol. 39(6), 487–493 (2011).
  • Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44(2), 156–163 (2001).
  • Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye (Lond.) 21(4), 465–471 (2007).
  • McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA. Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clin. Experiment. Ophthalmol. 31(5), 397–402 (2003).
  • Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathy in patients with Type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361(9353), 195–200 (2003).
  • Wong TY, Mwamburi M, Klein R et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 32(12), 2307–2313 (2009).
  • Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet. Med. 27(3), 249–256 (2010).
  • Fong DS, Gottlieb J, Ferris FL 3rd, Klein R. Understanding the value of diabetic retinopathy screening. Arch. Ophthalmol. 119(5), 758–760 (2001).
  • Klein R. Screening interval for retinopathy in Type 2 diabetes. Lancet 361(9353), 190–191 (2003).
  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch. Ophthalmol. 107(2), 244–249 (1989).
  • Manaviat MR, Rashidi M, Afkhami-Ardekani M. Four years incidence of diabetic retinopathy and effective factors on its progression in Type II diabetes. Eur. J. Ophthalmol. 18(4), 572–577 (2008).
  • Ferris F. Early photocoagulation in patients with either Type I or Type II diabetes. Trans. Am. Ophthalmol. Soc. 94, 505–537 (1996).
  • The Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. Int. Ophthalmol. Clin. 27(4), 239–253 (1987).
  • Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch. Ophthalmol. 103(12), 1796–1806 (1985).
  • NICE. Retinopathy – screening and early management. In: Management of Type 2 Diabetes. NICE, London, UK (2002).
  • Javitt JC, Aiello LP, Bassi LJ, Chiang YP, Canner JK. Detecting and treating retinopathy in patients with Type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Ophthalmology 98(10), 1565–1573; discussion 1574 (1991).
  • Hutchinson A, McIntosh A, Peters J et al. Effectiveness of screening and monitoring tests for diabetic retinopathy – a systematic review. Diabet. Med. 17(7), 495–506 (2000).
  • Joannou J, Kalk WJ, Mahomed I et al. Screening for diabetic retinopathy in South Africa with 60 degrees retinal colour photography. J. Intern. Med. 239(1), 43–47 (1996).
  • Maberley D, Cruess AF, Barile G, Slakter J. Digital photographic screening for diabetic retinopathy in the James Bay Cree. Ophthalmic Epidemiol. 9(3), 169–178 (2002).
  • Liesenfeld B, Kohner E, Piehlmeier W et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care 23(3), 345–348 (2000).
  • Fransen SR, Leonard-Martin TC, Feuer WJ, Hildebrand PL; Inoveon Health Research Group. Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology 109(3), 595–601 (2002).
  • Baeza M, Orozco-Beltrán D, Gil-Guillen VF et al. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate? Int. J. Clin. Pract. 63(3), 433–438 (2009).
  • Razvi S, Myers L, Patton K, McCulloch AJ. Screening for diabetic retinopathy: a cause for concern in people who drive. Diabet. Med. 20(10), 812–815 (2003).
  • Aptel F, Denis P, Rouberol F, Thivolet C. Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabetes Metab. 34(3), 290–293 (2008).
  • Harper CA, Livingston PM, Wood C et al. Screening for diabetic retinopathy using a non-mydriatic retinal camera in rural Victoria. Aust. N. Z. J. Ophthalmol. 26(2), 117–121 (1998).
  • Murgatroyd H, Ellingford A, Cox A et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br. J. Ophthalmol. 88(7), 920–924 (2004).
  • Williams R, Nussey S, Humphry R, Thompson G. Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. Br. Med. J. (Clin. Res. Ed.) 293(6555), 1140–1142 (1986).
  • Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 111(5), 1055–1062 (2004).
  • Diamond JP, McKinnon M, Barry C et al. Non-mydriatic fundus photography: a viable alternative to fundoscopy for identification of diabetic retinopathy in an Aboriginal population in rural Western Australia? Aust. N. Z. J. Ophthalmol. 26(2), 109–115 (1998).
  • Scanlon PH, Malhotra R, Greenwood RH et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br. J. Ophthalmol. 87(10), 1258–1263 (2003).
  • Pugh JA, Jacobson JM, Van Heuven WA et al. Screening for diabetic retinopathy. The wide-angle retinal camera. Diabetes Care 16(6), 889–895 (1993).
  • Bursell SE, Cavallerano JD, Cavallerano AA et al. Joslin Vision Network Research Team. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 108(3), 572–585 (2001).
  • Gómez-Ulla F, Fernandez MI, Gonzalez F et al. Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy. Diabetes Care 25(8), 1384–1389 (2002).
  • WHO. Prevention of blindness from diabetes mellitus. WHO, Geneva, Switzerland, 3–24 (2006).
  • Basu A. Digital image compression should be limited in diabetic retinopathy screening. J. Telemed. Telecare 12(4), 163–165 (2006).
  • Atan D, Foy C, Scanlon PH. Reply to ‘Evaluation of the effect of JPEG and JPEG2000 image compression on the detection of diabetic retinopathy’. Eye (Lond.) 22(3), 471; author reply 473 (2008).
  • Basu A, Kamal AD, Illahi W, Khan M, Stavrou P, Ryder RE. Is digital image compression acceptable within diabetic retinopathy screening? Diabet. Med. 20(9), 766–771 (2003).
  • Vujosevic S, Benetti E, Massignan F et al. Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am. J. Ophthalmol. 148(1), 111–118 (2009).
  • Lienert RT. Inter-observer comparisons of ophthalmoscopic assessment of diabetic retinopathy. Aust. N. Z. J. Ophthalmol. 17(4), 363–368 (1989).
  • Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ 311(7013), 1131–1135 (1995).
  • Lopez-Bastida J, Cabrera-Lopez F, Serrano-Aguilar P. Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy. Diabet. Med. 24(4), 403–407 (2007).
  • Wilson PJ, Ellis JD, MacEwen CJ, Ellingford A, Talbot J, Leese GP. Screening for diabetic retinopathy: a comparative trial of photography and scanning laser ophthalmoscopy. Ophthalmologica. 224(4), 251–257 (2010).
  • Heywood PF, Harahap NP. Human resources for health at the district level in Indonesia: the smoke and mirrors of decentralization. Hum. Resour. Health 7, 6 (2009).
  • Hon NH. Vietnam National Prevention of Blindness Programme and Vision 2020. Vietnam National Institute of Ophthalmology, Ha Noi, Vietnam (2005).
  • Kanchanachitra C, Lindelow M, Johnston T et al. Human resources for health in southeast Asia: shortages, distributional challenges, and international trade in health services. Lancet 377(9767), 769–781 (2011).
  • Buxton MJ, Sculpher MJ, Ferguson BA et al. Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet. Med. 8(4), 371–377 (1991).
  • Gill JM, Cole DM, Lebowitz HM, Diamond JJ. Accuracy of screening for diabetic retinopathy by family physicians. Ann. Fam. Med. 2(3), 218–220 (2004).
  • Kleinstein RN, Roseman JM, Herman WH, Holcombe J, Louv WC. Detection of diabetic retinopathy by optometrists. J. Am. Optom. Assoc. 58(11), 879–882 (1987).
  • Burnett S, Hurwitz B, Davey C et al. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet. Med. 15(Suppl. 3), S38–S43 (1998).
  • Forrest RD, Jackson CA, Yudkin JS. Screening for diabetic retinopathy – comparison of a nurse and a doctor with retinal photography. Diabetes Res. 5(1), 39–42 (1987).
  • Ting D, Ng J, Morlet N et al. Diabetic retinopathy – screening and management by Australian GPs. Aust. Fam. Physician 40(4), 233–238 (2011).
  • Jackson CL, Hirst L, de Jong IC, Smith N. Can Australian general practitioners effectively screen for diabetic retinopathy? A pilot study. BMC Fam. Pract. 3, 4 (2002).
  • Confos N, Frith J, Mitchell P. Training GPs to screen for diabetic retinopathy. The impact of short term intensive education. Aust. Fam. Physician 32(5), 381–382, 384 (2003).
  • Schmid KL, Swann PG, Pedersen C, Schmid LM. The detection of diabetic retinopathy by Australian optometrists. Clin. Exp. Optom. 85(4), 221–228 (2002).
  • Farley TF, Mandava N, Prall FR, Carsky C. Accuracy of primary care clinicians in screening for diabetic retinopathy using single-image retinal photography. Ann. Fam. Med. 6(5), 428–434 (2008).
  • Klein R, Klein BE, Neider MW, Hubbard LD, Meuer SM, Brothers RJ. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology 92(4), 485–491 (1985).
  • Andonegui J, Berástegui L, Serrano L, Eguzkiza A, Gaminde I, Aliseda D. [Agreement among ophthalmologists and primary care physicians in the evaluation of retinographies of diabetic patients]. Arch. Soc. Esp. Oftalmol. 83(9), 527–531 (2008).
  • ETDRS Report Number 7. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. Ophthalmology 98(Suppl. 5), 741–756 (1991).
  • Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Arch. Ophthalmol. 108(7), 958–964 (1990).
  • Sakamoto T, Miyazaki M, Hisatomi T et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch. Clin. Exp. Ophthalmol. 240(6), 423–429 (2002).
  • Smiddy WE, Flynn HW Jr. Vitrectomy in the management of diabetic retinopathy. Surv. Ophthalmol. 43(6), 491–507 (1999).
  • Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B. Vitrectomy for persistent diffuse diabetic macular edema. Am. J. Ophthalmol. 140(2), 295–301 (2005).
  • Doi N, Sakamoto T, Sonoda Y et al. Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes. Graefes Arch. Clin. Exp. Ophthalmol. 250(1), 71–78 (2012).
  • El-Asrar A, Al-Mezaine HS, Ola MS. Pathophysiology and management of diabetic retinopathy. Expert Rev. Ophthalmol. 4(6), 627–647 (2009).
  • Rajendram R, Fraser-Bell S, Kaines A et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-Month Data: Report 3. Arch. Ophthalmol. 130(8), 972–979 (2012).
  • Massin P, Bandello F, Garweg JG et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter Phase II study. Diabetes Care 33(11), 2399–2405 (2010).
  • Nguyen QD, Shah SM, Khwaja AA et al. READ-2 Study Group. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117(11), 2146–2151 (2010).
  • Elman MJ, Aiello LP, Beck RW et al. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117(6), 1064–1077.e35 (2010).
  • Elman MJ, Bressler NM, Qin H et al. Diabetic Retinopathy Clinical Research Network. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 118(4), 609–614 (2011).
  • Sultan MB, Zhou D, Loftus J, Dombi T, Ice KS; Macugen 1013 Study Group. A Phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology 118(6), 1107–1118 (2011).
  • Beck RW, Edwards AR, Aiello LP et al. Diabetic Retinopathy Clinical Research Network (DRCR.net). Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch. Ophthalmol. 127(3), 245–251 (2009).
  • Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113(9), 1533–1538 (2006).
  • WHO. Action plan for the prevention of avoidable blindness and visual impairment, 2009–2013. WHO, Geneva, Switzerland (2010).
  • Namperumalsamy P. Guidelines for the Comprehensive Management of Diabetic Retinopathy in India. Aravind Eye Care System, Madurai, India (2008).
  • von-Bischhoffshausen FB, Francisco MC, Gomez-Bastar P. Planning diabetic retinopathy services- lessons from Latin America. Community Eye Health 24(75), 14–16 (2011).
  • Tso MO. Changing scenery of eye care in China: from cataract to diabetic retinopathy. Arch. Ophthalmol. 130(2), 243–245 (2012).
  • NHMRC. Guidelines for the Management of Diabetic Retinopathy. NHMRC, Canberra, Australia (2008).
  • Namperumalsamy P. Guidelines for the Comprehensive Management of Diabetic Retinopathy in India. Aravind Eye Care System, Madurai, India (2008).
  • NICE. Retinopathy – Screening and Early Management. NICE, London, UK (2002).
  • NICE. Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update). NICE, London, UK (2008).
  • NICE. Management of diabetic eye disease. In: Type 1 Diabetes in Adults. National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. NICE, London, UK (2004).
  • NICE. Guidance in Practice – Diabetic Retinopathy: Drug Therapy. NICE, London, UK (2011).
  • NICE. Diabetes in Pregnancy. NICE, London, UK (2008).
  • RCO. Guidelines for Diabetic Retinopathy 2005. RCO, London (2005).
  • American Academy of Ophthalmology. Diabetic Retinopathy Preferred Practice Pattern. American Academy of Ophthalmology, San Francisco, CA, USA (2008).
  • Scottish Intercollegiate Guidelines Network. Prevention of visual impairment. In: Management of Diabetes – A National Clinical Guideline. Scottish Intercollegiate Guidelines Network, Ediburgh, UK (2010).
  • WHO. Prevention of Blindness from Diabetes Mellitus. Geneva, Switzerland (2006).
  • Ministry of Health. Screening of Diabetic Retinopathy. Ministry of Health, Putrajaya, Malaysia (2011).
  • Pacific Eye Institute. Diabetes Retinal Screening, Grading and Management Guidelines for Use in Pacific Island Nations, 2010. Diabetes Working Group, Fred Hollows Foundation, Pacific Eye Institute, Auckland, New Zealand (2010).
  • Hanas R, Donaghue KC, Klingensmith G, Swift PG. ISPAD clinical practice consensus guidelines 2009 compendium. Introduction. Pediatr. Diabetes 10(Suppl. 12), 1–2 (2009).
  • Department of Health. Diabetic retinopathy in: National guideline. Prevention of Blindness in South Africa. Department of Health, Republic of South Africa (2002).
  • Canadian Diabetes Association. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Diabetes Association, Canada (2008).

References

  • National diabetes retinal screening grading system and referral guidelines. Ministry of Health, New Zealand Government, Wellington, New Zealand (2008).
  • Care of the patient with diabetes mellitus. American Optometric Association, St Louis, MO, USA (2009).
  • King GL. Screening for diabetic retinopathy. Diabetes Care 25(Suppl. 1), 90–93 (2002).
  • ADS. National evidence-based clinical care guidelines for Type 1 diabetes in children, adolescents and adults. Australian Diabetes Society, Sydney, Australia (2011).
  • ICO. Diabetic retinopathy (management recommendations). International Council of Ophthalmology, San Francisco, CA, USA (2011).
  • RCO. Preferred practice guideline. Diabetic retinopathy screening (DRS) and the ophthalmology clinic set up in England. The Royal College of Ophthalmologists, London, UK (2010).
  • Facey K, Cummins E, Macpherson K, Morris A, Reay L, Slattery J. Organisation of services for diabetic retinopathy screening. Health Technology Board for Scotland, Glasgow, UK (2002).
  • Retinopathy in: National clinical guidelines for management of diabetes mellitus. Ministry of Public Health and Sanitation, Nairobi, Kenya (2010).
  • Pareja-Ríos A, Serrano-García MA, Marrero-Saavedra MD et al. [Guidelines of clinical practice of the SERV (Spanish Retina and Vitreous Society): management of ocular complications of diabetes. Diabetic retinopathy and macular oedema]. Arch. Soc. Esp. Oftalmol. 84(9), 429–450 (2009).
  • Claudi T, Cooper J, Midthjell K, Daae C, Furuseth K, Hanssen K. NSAMs guidelines for diabetes in general practice. Norsk selskap for allmennmedisin, Norges Diabetesforbund, Den norske Lægeforening (2000).
  • Summanen P, Kallionienmi V, Komulainen J et al. Diabetic retinopathy. Current care summary. The Ophthalmological Society of Finland, Finland (2006).
  • Millán-Gámez YK, Wacher-Rodarte NH, Bravo-Ortiz JC et al. [Clinical practice guidelines. Diagnosis and treatment of diabetic retinopathy]. Rev. Med. Inst. Mex. Seguro Soc. 49(5), 551–562 (2011).
  • Petrovic M, Urbancic M, Sevsek D. Guidelines for screening and treatment for diabetic retinopathy. Slovenian Med. J. 79(Suppl.), 7–18 (2010).
  • Takagi H. [Guideline-based planning for the treatment of diabetic retinopathy]. Nippon. Rinsho. 68(Suppl. 9), 291–297 (2010).
  • [Recommendation of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany: treatment of diabetic maculopathy]. Klin Monbl Augenheilkd 228(5), 446–459 (2011).
  • Polak BC, Hartstra WW, Ringens PJ, Scholten RJ. [Revised guideline ‘Diabetic retinopathy: screening, diagnosis and treatment’]. Ned. Tijdschr. Geneeskd. 152(44), 2406–2413 (2008).
  • Deb N, Thuret G, Estour B, Massin P, Gain P. Screening for diabetic retinopathy in France. Diabetes Metab. 30(2), 140–145 (2004).
  • ICO. Clinical practice guidelines – diabetic retinopathy, Latin America. ICO International Agency for the Prevention of Blindness (IAPB), Ecuador (2011).
  • Kalvodová B. [Screening for diabetic retinopathy in the Czech Republic – guideline]. Cesk. Slov. Oftalmol. 58(1), 3–10 (2002).
  • RCO. Guidelines for diabetic retinopathy 2005. The Royal College of Ophthalmologists, London, UK, 2–72 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.